SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1ns3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1435_1 (CHITINASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 6	GLY A 137 PHE A 43 SER A 139 ARG A 109	None	1.31A	2a3cA-1ns3A: undetectable	2a3cA-1ns3A: 20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_B_PNXB2434_1 (CHITINASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 6	GLY A 137 PHE A 43 SER A 139 ARG A 109	None	1.29A	2a3cB-1ns3A: undetectable	2a3cB-1ns3A: 20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OC8_A_HU5A999_1 (HEPATITIS C VIRUS)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 ARG A 123 LEU A 135 GLY A 137 SER A 139 PHE A 154 ALA A 156 ALA A 157 VAL A 158	None	0.80A	2oc8A-1ns3A: 31.5	2oc8A-1ns3A: 81.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OC8_A_HU5A999_1 (HEPATITIS C VIRUS)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 HIS A 57 LEU A 135 GLY A 137 SER A 139 PHE A 154 ALA A 156 ALA A 157 VAL A 158	None	0.61A	2oc8A-1ns3A: 31.5	2oc8A-1ns3A: 81.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OC8_A_HU5A999_1 (HEPATITIS C VIRUS)	1ns3	NS3 PROTEASE (Hepacivirus C)	7 / 12	LEU A 135 GLY A 137 SER A 139 PHE A 154 ARG A 155 ALA A 156 ALA A 157	None	0.78A	2oc8A-1ns3A: 31.5	2oc8A-1ns3A: 81.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PGR_A_DCFA501_2 (ADENOSINE DEAMINASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	3 / 3	LEU A 104 LEU A 94 PHE A 169	None	0.63A	2pgrA-1ns3A: undetectable	2pgrA-1ns3A: 18.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_A_30BA500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	HIS A 57 ASP A 81 GLY A 137 SER A 139 ARG A 155 ASP A 168	None	1.35A	3keeA-1ns3A: 32.7	3keeA-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_A_30BA500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 ARG A 155 ASP A 168	None	1.19A	3keeA-1ns3A: 32.7	3keeA-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_A_30BA500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157 ASP A 168	None	0.72A	3keeA-1ns3A: 32.7	3keeA-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_A_30BA500_2 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 4	GLN A 41 PHE A 43 TYR A 56 VAL A 132	None	0.73A	3keeA-1ns3A: 32.7	3keeA-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_B_30BB500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 VAL A 132 PHE A 154 ALA A 156 ALA A 157	None	0.82A	3keeB-1ns3A: 32.7	3keeB-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_B_30BB500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 ARG A 155	None	0.93A	3keeB-1ns3A: 32.7	3keeB-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_B_30BB500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 VAL A 132 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.59A	3keeB-1ns3A: 32.7	3keeB-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_B_30BB500_2 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	3 / 3	PHE A 43 TYR A 56 LEU A 135	None	0.45A	3keeB-1ns3A: 32.7	3keeB-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_C_30BC500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 ARG A 155	None	0.98A	3keeC-1ns3A: 32.8	3keeC-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_C_30BC500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 VAL A 132 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.59A	3keeC-1ns3A: 32.8	3keeC-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_C_30BC500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	7 / 12	HIS A 57 VAL A 132 GLY A 137 PHE A 154 ALA A 156 ALA A 157 ASP A 168	None	0.96A	3keeC-1ns3A: 32.8	3keeC-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 HIS A 57 ASP A 81 GLY A 137 SER A 139 ASP A 168	None	1.07A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 GLY A 137 ALA A 156 ALA A 157 ASP A 168	None	0.84A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 ARG A 155 ASP A 168	None	1.21A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157 ASP A 168	None	0.65A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	LYS A 136 GLY A 137 PHE A 154 ALA A 156 ALA A 157 ASP A 168	None	0.97A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KEE_D_30BD500_2 (GENOME POLYPROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 4	PHE A 43 TYR A 56 VAL A 132 LEU A 135	None	0.59A	3keeD-1ns3A: 32.6	3keeD-1ns3A: 96.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MTE_B_SAMB220_0 (16S RRNA METHYLASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLY A 141 VAL A 55 ALA A 156 ALA A 157 LEU A 135	None	1.01A	3mteB-1ns3A: undetectable	3mteB-1ns3A: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P2K_C_SAMC6735_0 (16S RRNA METHYLASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLY A 141 VAL A 55 ALA A 156 ALA A 157 LEU A 135	None	1.02A	3p2kC-1ns3A: undetectable	3p2kC-1ns3A: 19.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 ARG A 123 PHE A 154 ALA A 156 ALA A 157	None	0.78A	3sudA-1ns3A: 30.5	3sudA-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.55A	3sudA-1ns3A: 30.5	3sudA-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 PHE A 43 TYR A 56 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156	None	0.70A	3sudB-1ns3A: 18.3	3sudB-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 ALA A 156 ALA A 157	None	0.84A	3sudC-1ns3A: 29.7	3sudC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 GLY A 137 ARG A 155	None	1.06A	3sudC-1ns3A: 29.7	3sudC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.65A	3sudC-1ns3A: 29.7	3sudC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157 ASP A 168	None	0.82A	3sudD-1ns3A: 30.6	3sudD-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUD_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 HIS A 57 GLY A 58 VAL A 78 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.79A	3sudD-1ns3A: 30.6	3sudD-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLN A 41 HIS A 57 ASP A 81 GLY A 137 SER A 139	None	0.95A	3sueA-1ns3A: 30.8	3sueA-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.69A	3sueA-1ns3A: 30.8	3sueA-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_A_SUEA1201_2 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 4	PHE A 43 TYR A 56 ARG A 123 LEU A 135	None	0.55A	3sueA-1ns3A: 30.8	3sueA-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 ARG A 123 PHE A 154 ALA A 156 ALA A 157	None	0.75A	3sueB-1ns3A: 30.6	3sueB-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.58A	3sueB-1ns3A: 30.6	3sueB-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_B_SUEB1201_2 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	3 / 3	PHE A 43 TYR A 56 LEU A 135	None	0.40A	3sueB-1ns3A: 30.6	3sueB-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 HIS A 57 GLY A 58 VAL A 78 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.72A	3sueC-1ns3A: 30.4	3sueC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 HIS A 57 VAL A 78 ASP A 81 GLY A 137 SER A 139	None	0.92A	3sueC-1ns3A: 30.4	3sueC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 VAL A 78 ASP A 81 GLY A 137 PHE A 154 ALA A 157 ASP A 168	None	0.68A	3sueC-1ns3A: 30.4	3sueC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	HIS A 57 VAL A 78 ASP A 81 GLY A 137 SER A 139 ASP A 168	None	1.01A	3sueC-1ns3A: 30.4	3sueC-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLN A 41 HIS A 57 ASP A 81 GLY A 137 SER A 139	None	1.06A	3sueD-1ns3A: 30.7	3sueD-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 PHE A 43 HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 ALA A 156	None	0.83A	3sueD-1ns3A: 30.7	3sueD-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUE_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	PHE A 43 HIS A 57 GLY A 58 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ALA A 156	None	0.56A	3sueD-1ns3A: 30.7	3sueD-1ns3A: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLN A 41 HIS A 57 ASP A 81 GLY A 137 SER A 139	None	1.06A	3sufA-1ns3A: 30.3	3sufA-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 HIS A 57 GLY A 58 ASP A 81 GLY A 137 ALA A 157	None	0.80A	3sufA-1ns3A: 30.3	3sufA-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	HIS A 57 ARG A 123 LEU A 135 GLY A 137 PHE A 154 ALA A 157	None	0.84A	3sufA-1ns3A: 30.3	3sufA-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 ASP A 81 LEU A 135 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.49A	3sufA-1ns3A: 30.3	3sufA-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	10 / 12	GLN A 41 PHE A 43 VAL A 55 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.68A	3sufB-1ns3A: 30.8	3sufB-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 VAL A 55 HIS A 57 ASP A 81 GLY A 137 SER A 139	None	0.91A	3sufB-1ns3A: 30.8	3sufB-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_B_SUEB1201_3 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 5	SER A 128 ARG A 130 PRO A 131 VAL A 163	None	1.10A	3sufC-1ns3A: 29.8	3sufC-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	10 / 11	GLN A 41 PHE A 43 TYR A 56 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.66A	3sufC-1ns3A: 29.8	3sufC-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_C_SUEC1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 11	GLN A 41 TYR A 56 HIS A 57 ASP A 81 GLY A 137 SER A 139	None	0.93A	3sufC-1ns3A: 29.8	3sufC-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	7 / 12	HIS A 57 GLY A 58 GLY A 137 SER A 139 PHE A 154 ALA A 156 CYH A 159	None	0.91A	3sufD-1ns3A: 29.1	3sufD-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 VAL A 78 GLY A 137 SER A 139 PHE A 154 ALA A 156 ALA A 157	None	0.82A	3sufD-1ns3A: 29.1	3sufD-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	VAL A 55 HIS A 57 GLY A 58 ASP A 81 GLY A 137 PHE A 154 ALA A 156 CYH A 159	None	0.60A	3sufD-1ns3A: 29.1	3sufD-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_D_SUED1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	VAL A 55 HIS A 57 GLY A 58 VAL A 78 ASP A 81 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.52A	3sufD-1ns3A: 29.1	3sufD-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUF_D_SUED1201_2 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 5	GLN A 41 PHE A 43 TYR A 56 ARG A 155	None	1.29A	3sufD-1ns3A: 29.1	3sufD-1ns3A: 78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUG_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	10 / 12	HIS A 57 GLY A 58 VAL A 78 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ARG A 155 ALA A 157 ASP A 168	None	0.58A	3sugA-1ns3A: 30.3	3sugA-1ns3A: 77.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SUG_A_SUEA1201_2 (NS3 PROTEASE, NS4A PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 5	GLN A 41 PHE A 43 TYR A 56 LEU A 135	None	0.85A	3sugA-1ns3A: 30.3	3sugA-1ns3A: 77.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NKV_C_AERC601_2 (STEROID 17-ALPHA-HYDROXYLASE /17,20 LYASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 6	TYR A 134 LEU A 44 VAL A 151 ALA A 150	None	0.92A	4nkvC-1ns3A: 0.0	4nkvC-1ns3A: 16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XTA_A_DIFA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 9	ALA A 157 LEU A 106 LEU A 143 ILE A 153	None	0.91A	4xtaA-1ns3A: undetectable	4xtaA-1ns3A: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MXB_A_ML1A220_1 (CLASS 10 PLANT PATHOGENESIS-RELATED PROTEIN)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	LEU A 106 VAL A 113 LEU A 127 TYR A 105 VAL A 151	None	1.31A	5mxbA-1ns3A: 0.1	5mxbA-1ns3A: 15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_D_C2FD3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	MET A 175 VAL A 48 LEU A 94 GLY A 140 SER A 139 ILE A 153	None	1.49A	5vooD-1ns3A: undetectable	5vooD-1ns3A: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_D_C2FD3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	MET A 175 VAL A 48 LEU A 94 GLY A 141 SER A 139 ILE A 153	None	1.46A	5vooD-1ns3A: undetectable	5vooD-1ns3A: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_E_C2FE3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	MET A 175 VAL A 48 LEU A 94 GLY A 141 SER A 139 ILE A 153	None	1.35A	5vooE-1ns3A: undetectable	5vooE-1ns3A: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_B_BEZB201_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	4 / 5	HIS A 57 ALA A 156 SER A 139 GLY A 140	None	1.16A	5yodB-1ns3A: 12.8	5yodB-1ns3A: 23.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_A_SUEA1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLN A 41 HIS A 57 VAL A 78 GLY A 137 SER A 139	None	0.96A	6c2mA-1ns3A: 30.5	6c2mA-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_A_SUEA1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	10 / 12	GLN A 41 PHE A 43 HIS A 57 GLY A 58 VAL A 78 ARG A 123 LEU A 135 GLY A 137 PHE A 154 ALA A 156	None	0.82A	6c2mA-1ns3A: 30.5	6c2mA-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_A_SUEA1202_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	VAL A 55 ASP A 81 ALA A 157 VAL A 158 ASP A 168	None	0.74A	6c2mA-1ns3A: 30.5	6c2mA-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_B_SUEB1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	GLN A 41 HIS A 57 VAL A 78 GLY A 137 SER A 139	None	0.99A	6c2mB-1ns3A: 18.2	6c2mB-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_B_SUEB1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	GLN A 41 PHE A 43 HIS A 57 GLY A 58 VAL A 78 ARG A 123 GLY A 137 PHE A 154 ALA A 156	None	0.81A	6c2mB-1ns3A: 18.2	6c2mB-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_B_SUEB1202_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	VAL A 55 ASP A 81 LEU A 135 ALA A 157 ASP A 168	None	0.85A	6c2mB-1ns3A: 18.2	6c2mB-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_B_SUEB1202_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	VAL A 55 ASP A 81 LEU A 135 ALA A 157 VAL A 158	None	0.42A	6c2mB-1ns3A: 18.2	6c2mB-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_C_SUEC1203_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 VAL A 78 ASP A 81 ARG A 123 GLY A 137 ALA A 157 VAL A 158	None	0.87A	6c2mC-1ns3A: 30.6	6c2mC-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_C_SUEC1203_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 12	GLN A 41 HIS A 57 VAL A 78 ASP A 81 GLY A 137 SER A 139	None	1.01A	6c2mC-1ns3A: 30.6	6c2mC-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_C_SUEC1203_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	9 / 12	HIS A 57 VAL A 78 ASP A 81 ARG A 123 GLY A 137 PHE A 154 ALA A 156 ALA A 157 VAL A 158	None	0.66A	6c2mC-1ns3A: 30.6	6c2mC-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_C_SUEC1203_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	PHE A 43 VAL A 55 GLY A 58 ARG A 155 ASP A 168	None	1.28A	6c2mC-1ns3A: 30.6	6c2mC-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_C_SUEC1203_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 9	PHE A 43 VAL A 55 GLY A 58 LEU A 135 ASP A 168	None	0.79A	6c2mC-1ns3A: 30.6	6c2mC-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_D_SUED1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	GLN A 41 HIS A 57 GLY A 58 VAL A 78 ARG A 123 GLY A 137 ALA A 156 ALA A 157	None	0.85A	6c2mD-1ns3A: 30.4	6c2mD-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_D_SUED1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	8 / 12	HIS A 57 GLY A 58 VAL A 78 ARG A 123 GLY A 137 PHE A 154 ALA A 156 ALA A 157	None	0.63A	6c2mD-1ns3A: 30.4	6c2mD-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_D_SUED1202_0 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	5 / 12	HIS A 57 GLY A 58 VAL A 78 GLY A 137 ARG A 155	None	1.02A	6c2mD-1ns3A: 30.4	6c2mD-1ns3A: 39.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C2M_D_SUED1202_1 (NS3 PROTEASE)	1ns3	NS3 PROTEASE (Hepacivirus C)	6 / 9	PHE A 43 VAL A 55 ASP A 81 LEU A 135 VAL A 158 ASP A 168	None	0.67A	6c2mD-1ns3A: 30.4	6c2mD-1ns3A: 39.37

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2A3C_A_PNXA1435_1","CHITINASE","1ns3","NS3 PROTEASE","Hepacivirus C",4,"GLY A 137;PHE A  43;SER A 139;ARG A 109","None","1.31A","2a3cA-1ns3A:undetectable","2a3cA-1ns3A:20.05"],["2A3C_B_PNXB2434_1","CHITINASE","1ns3","NS3 PROTEASE","Hepacivirus C",4,"GLY A 137;PHE A  43;SER A 139;ARG A 109","None","1.29A","2a3cB-1ns3A:undetectable","2a3cB-1ns3A:20.05"],["2OC8_A_HU5A999_1","HEPATITIS C VIRUS","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;ARG A 123;LEU A 135;GLY A 137;SER A 139;PHE A 154;ALA A 156;ALA A 157;VAL A 158","None","0.80A","2oc8A-1ns3A:31.5","2oc8A-1ns3A:81.73"],["2OC8_A_HU5A999_1","HEPATITIS C VIRUS","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;HIS A  57;LEU A 135;GLY A 137;SER A 139;PHE A 154;ALA A 156;ALA A 157;VAL A 158","None","0.61A","2oc8A-1ns3A:31.5","2oc8A-1ns3A:81.73"],["2OC8_A_HU5A999_1","HEPATITIS C VIRUS","1ns3","NS3 PROTEASE","Hepacivirus C",7,"LEU A 135;GLY A 137;SER A 139;PHE A 154;ARG A 155;ALA A 156;ALA A 157","None","0.78A","2oc8A-1ns3A:31.5","2oc8A-1ns3A:81.73"],["2PGR_A_DCFA501_2","ADENOSINE DEAMINASE","1ns3","NS3 PROTEASE","Hepacivirus C",3,"LEU A 104;LEU A  94;PHE A 169","None","0.63A","2pgrA-1ns3A:undetectable","2pgrA-1ns3A:18.85"],["3KEE_A_30BA500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"HIS A  57;ASP A  81;GLY A 137;SER A 139;ARG A 155;ASP A 168","None","1.35A","3keeA-1ns3A:32.7","3keeA-1ns3A:96.26"],["3KEE_A_30BA500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;ARG A 155;ASP A 168","None","1.19A","3keeA-1ns3A:32.7","3keeA-1ns3A:96.26"],["3KEE_A_30BA500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157;ASP A 168","None","0.72A","3keeA-1ns3A:32.7","3keeA-1ns3A:96.26"],["3KEE_A_30BA500_2","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"GLN A  41;PHE A  43;TYR A  56;VAL A 132","None","0.73A","3keeA-1ns3A:32.7","3keeA-1ns3A:96.26"],["3KEE_B_30BB500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;VAL A 132;PHE A 154;ALA A 156;ALA A 157","None","0.82A","3keeB-1ns3A:32.7","3keeB-1ns3A:96.26"],["3KEE_B_30BB500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;ARG A 155","None","0.93A","3keeB-1ns3A:32.7","3keeB-1ns3A:96.26"],["3KEE_B_30BB500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;VAL A 132;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.59A","3keeB-1ns3A:32.7","3keeB-1ns3A:96.26"],["3KEE_B_30BB500_2","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",3,"PHE A  43;TYR A  56;LEU A 135","None","0.45A","3keeB-1ns3A:32.7","3keeB-1ns3A:96.26"],["3KEE_C_30BC500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;ARG A 155","None","0.98A","3keeC-1ns3A:32.8","3keeC-1ns3A:96.26"],["3KEE_C_30BC500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;VAL A 132;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.59A","3keeC-1ns3A:32.8","3keeC-1ns3A:96.26"],["3KEE_C_30BC500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",7,"HIS A  57;VAL A 132;GLY A 137;PHE A 154;ALA A 156;ALA A 157;ASP A 168","None","0.96A","3keeC-1ns3A:32.8","3keeC-1ns3A:96.26"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;HIS A  57;ASP A  81;GLY A 137;SER A 139;ASP A 168","None","1.07A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;GLY A 137;ALA A 156;ALA A 157;ASP A 168","None","0.84A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;ARG A 155;ASP A 168","None","1.21A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157;ASP A 168","None","0.65A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"LYS A 136;GLY A 137;PHE A 154;ALA A 156;ALA A 157;ASP A 168","None","0.97A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3KEE_D_30BD500_2","GENOME POLYPROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"PHE A  43;TYR A  56;VAL A 132;LEU A 135","None","0.59A","3keeD-1ns3A:32.6","3keeD-1ns3A:96.26"],["3MTE_B_SAMB220_0","16S RRNA METHYLASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLY A 141;VAL A  55;ALA A 156;ALA A 157;LEU A 135","None","1.01A","3mteB-1ns3A:undetectable","3mteB-1ns3A:19.57"],["3P2K_C_SAMC6735_0","16S RRNA METHYLASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLY A 141;VAL A  55;ALA A 156;ALA A 157;LEU A 135","None","1.02A","3p2kC-1ns3A:undetectable","3p2kC-1ns3A:19.65"],["3SUD_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;ARG A 123;PHE A 154;ALA A 156;ALA A 157","None","0.78A","3sudA-1ns3A:30.5","3sudA-1ns3A:77.50"],["3SUD_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.55A","3sudA-1ns3A:30.5","3sudA-1ns3A:77.50"],["3SUD_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;PHE A  43;TYR A  56;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156","None","0.70A","3sudB-1ns3A:18.3","3sudB-1ns3A:77.50"],["3SUD_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;ALA A 156;ALA A 157","None","0.84A","3sudC-1ns3A:29.7","3sudC-1ns3A:77.50"],["3SUD_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;GLY A 137;ARG A 155","None","1.06A","3sudC-1ns3A:29.7","3sudC-1ns3A:77.50"],["3SUD_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.65A","3sudC-1ns3A:29.7","3sudC-1ns3A:77.50"],["3SUD_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157;ASP A 168","None","0.82A","3sudD-1ns3A:30.6","3sudD-1ns3A:77.50"],["3SUD_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;HIS A  57;GLY A  58;VAL A  78;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.79A","3sudD-1ns3A:30.6","3sudD-1ns3A:77.50"],["3SUE_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLN A  41;HIS A  57;ASP A  81;GLY A 137;SER A 139","None","0.95A","3sueA-1ns3A:30.8","3sueA-1ns3A:77.50"],["3SUE_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.69A","3sueA-1ns3A:30.8","3sueA-1ns3A:77.50"],["3SUE_A_SUEA1201_2","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"PHE A  43;TYR A  56;ARG A 123;LEU A 135","None","0.55A","3sueA-1ns3A:30.8","3sueA-1ns3A:77.50"],["3SUE_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;ARG A 123;PHE A 154;ALA A 156;ALA A 157","None","0.75A","3sueB-1ns3A:30.6","3sueB-1ns3A:77.50"],["3SUE_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.58A","3sueB-1ns3A:30.6","3sueB-1ns3A:77.50"],["3SUE_B_SUEB1201_2","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",3,"PHE A  43;TYR A  56;LEU A 135","None","0.40A","3sueB-1ns3A:30.6","3sueB-1ns3A:77.50"],["3SUE_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;HIS A  57;GLY A  58;VAL A  78;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.72A","3sueC-1ns3A:30.4","3sueC-1ns3A:77.50"],["3SUE_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;HIS A  57;VAL A  78;ASP A  81;GLY A 137;SER A 139","None","0.92A","3sueC-1ns3A:30.4","3sueC-1ns3A:77.50"],["3SUE_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;VAL A  78;ASP A  81;GLY A 137;PHE A 154;ALA A 157;ASP A 168","None","0.68A","3sueC-1ns3A:30.4","3sueC-1ns3A:77.50"],["3SUE_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"HIS A  57;VAL A  78;ASP A  81;GLY A 137;SER A 139;ASP A 168","None","1.01A","3sueC-1ns3A:30.4","3sueC-1ns3A:77.50"],["3SUE_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLN A  41;HIS A  57;ASP A  81;GLY A 137;SER A 139","None","1.06A","3sueD-1ns3A:30.7","3sueD-1ns3A:77.50"],["3SUE_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;PHE A  43;HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;ALA A 156","None","0.83A","3sueD-1ns3A:30.7","3sueD-1ns3A:77.50"],["3SUE_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"PHE A  43;HIS A  57;GLY A  58;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ALA A 156","None","0.56A","3sueD-1ns3A:30.7","3sueD-1ns3A:77.50"],["3SUF_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLN A  41;HIS A  57;ASP A  81;GLY A 137;SER A 139","None","1.06A","3sufA-1ns3A:30.3","3sufA-1ns3A:78.00"],["3SUF_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;HIS A  57;GLY A  58;ASP A  81;GLY A 137;ALA A 157","None","0.80A","3sufA-1ns3A:30.3","3sufA-1ns3A:78.00"],["3SUF_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"HIS A  57;ARG A 123;LEU A 135;GLY A 137;PHE A 154;ALA A 157","None","0.84A","3sufA-1ns3A:30.3","3sufA-1ns3A:78.00"],["3SUF_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;ASP A  81;LEU A 135;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.49A","3sufA-1ns3A:30.3","3sufA-1ns3A:78.00"],["3SUF_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",10,"GLN A  41;PHE A  43;VAL A  55;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.68A","3sufB-1ns3A:30.8","3sufB-1ns3A:78.00"],["3SUF_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;VAL A  55;HIS A  57;ASP A  81;GLY A 137;SER A 139","None","0.91A","3sufB-1ns3A:30.8","3sufB-1ns3A:78.00"],["3SUF_B_SUEB1201_3","NS3 PROTEASE, NS4A PROTEIN;NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"SER A 128;ARG A 130;PRO A 131;VAL A 163","None","1.10A","3sufC-1ns3A:29.8","3sufC-1ns3A:78.00"],["3SUF_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",10,"GLN A  41;PHE A  43;TYR A  56;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.66A","3sufC-1ns3A:29.8","3sufC-1ns3A:78.00"],["3SUF_C_SUEC1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;TYR A  56;HIS A  57;ASP A  81;GLY A 137;SER A 139","None","0.93A","3sufC-1ns3A:29.8","3sufC-1ns3A:78.00"],["3SUF_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",7,"HIS A  57;GLY A  58;GLY A 137;SER A 139;PHE A 154;ALA A 156;CYH A 159","None","0.91A","3sufD-1ns3A:29.1","3sufD-1ns3A:78.00"],["3SUF_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;VAL A  78;GLY A 137;SER A 139;PHE A 154;ALA A 156;ALA A 157","None","0.82A","3sufD-1ns3A:29.1","3sufD-1ns3A:78.00"],["3SUF_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",8,"VAL A  55;HIS A  57;GLY A  58;ASP A  81;GLY A 137;PHE A 154;ALA A 156;CYH A 159","None","0.60A","3sufD-1ns3A:29.1","3sufD-1ns3A:78.00"],["3SUF_D_SUED1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",9,"VAL A  55;HIS A  57;GLY A  58;VAL A  78;ASP A  81;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.52A","3sufD-1ns3A:29.1","3sufD-1ns3A:78.00"],["3SUF_D_SUED1201_2","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"GLN A  41;PHE A  43;TYR A  56;ARG A 155","None","1.29A","3sufD-1ns3A:29.1","3sufD-1ns3A:78.00"],["3SUG_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",10,"HIS A  57;GLY A  58;VAL A  78;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ARG A 155;ALA A 157;ASP A 168","None","0.58A","3sugA-1ns3A:30.3","3sugA-1ns3A:77.00"],["3SUG_A_SUEA1201_2","NS3 PROTEASE, NS4A PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",4,"GLN A  41;PHE A  43;TYR A  56;LEU A 135","None","0.85A","3sugA-1ns3A:30.3","3sugA-1ns3A:77.00"],["4NKV_C_AERC601_2","STEROID 17-ALPHA-HYDROXYLASE\/17,20 LYASE","1ns3","NS3 PROTEASE","Hepacivirus C",4,"TYR A 134;LEU A  44;VAL A 151;ALA A 150","None","0.92A","4nkvC-1ns3A:0.0","4nkvC-1ns3A:16.80"],["4XTA_A_DIFA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1ns3","NS3 PROTEASE","Hepacivirus C",4,"ALA A 157;LEU A 106;LEU A 143;ILE A 153","None","0.91A","4xtaA-1ns3A:undetectable","4xtaA-1ns3A:20.83"],["5MXB_A_ML1A220_1","CLASS 10 PLANT PATHOGENESIS-RELATED PROTEIN","1ns3","NS3 PROTEASE","Hepacivirus C",5,"LEU A 106;VAL A 113;LEU A 127;TYR A 105;VAL A 151","None","1.31A","5mxbA-1ns3A:0.1","5mxbA-1ns3A:15.85"],["5VOO_D_C2FD3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","1ns3","NS3 PROTEASE","Hepacivirus C",6,"MET A 175;VAL A  48;LEU A  94;GLY A 140;SER A 139;ILE A 153","None","1.49A","5vooD-1ns3A:undetectable","5vooD-1ns3A:20.95"],["5VOO_D_C2FD3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","1ns3","NS3 PROTEASE","Hepacivirus C",6,"MET A 175;VAL A  48;LEU A  94;GLY A 141;SER A 139;ILE A 153","None","1.46A","5vooD-1ns3A:undetectable","5vooD-1ns3A:20.95"],["5VOO_E_C2FE3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","1ns3","NS3 PROTEASE","Hepacivirus C",6,"MET A 175;VAL A  48;LEU A  94;GLY A 141;SER A 139;ILE A 153","None","1.35A","5vooE-1ns3A:undetectable","5vooE-1ns3A:20.95"],["5YOD_B_BEZB201_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",4,"HIS A  57;ALA A 156;SER A 139;GLY A 140","None","1.16A","5yodB-1ns3A:12.8","5yodB-1ns3A:23.81"],["6C2M_A_SUEA1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLN A  41;HIS A  57;VAL A  78;GLY A 137;SER A 139","None","0.96A","6c2mA-1ns3A:30.5","6c2mA-1ns3A:39.37"],["6C2M_A_SUEA1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",10,"GLN A  41;PHE A  43;HIS A  57;GLY A  58;VAL A  78;ARG A 123;LEU A 135;GLY A 137;PHE A 154;ALA A 156","None","0.82A","6c2mA-1ns3A:30.5","6c2mA-1ns3A:39.37"],["6C2M_A_SUEA1202_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"VAL A  55;ASP A  81;ALA A 157;VAL A 158;ASP A 168","None","0.74A","6c2mA-1ns3A:30.5","6c2mA-1ns3A:39.37"],["6C2M_B_SUEB1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"GLN A  41;HIS A  57;VAL A  78;GLY A 137;SER A 139","None","0.99A","6c2mB-1ns3A:18.2","6c2mB-1ns3A:39.37"],["6C2M_B_SUEB1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",9,"GLN A  41;PHE A  43;HIS A  57;GLY A  58;VAL A  78;ARG A 123;GLY A 137;PHE A 154;ALA A 156","None","0.81A","6c2mB-1ns3A:18.2","6c2mB-1ns3A:39.37"],["6C2M_B_SUEB1202_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"VAL A  55;ASP A  81;LEU A 135;ALA A 157;ASP A 168","None","0.85A","6c2mB-1ns3A:18.2","6c2mB-1ns3A:39.37"],["6C2M_B_SUEB1202_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"VAL A  55;ASP A  81;LEU A 135;ALA A 157;VAL A 158","None","0.42A","6c2mB-1ns3A:18.2","6c2mB-1ns3A:39.37"],["6C2M_C_SUEC1203_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;VAL A  78;ASP A  81;ARG A 123;GLY A 137;ALA A 157;VAL A 158","None","0.87A","6c2mC-1ns3A:30.6","6c2mC-1ns3A:39.37"],["6C2M_C_SUEC1203_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",6,"GLN A  41;HIS A  57;VAL A  78;ASP A  81;GLY A 137;SER A 139","None","1.01A","6c2mC-1ns3A:30.6","6c2mC-1ns3A:39.37"],["6C2M_C_SUEC1203_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",9,"HIS A  57;VAL A  78;ASP A  81;ARG A 123;GLY A 137;PHE A 154;ALA A 156;ALA A 157;VAL A 158","None","0.66A","6c2mC-1ns3A:30.6","6c2mC-1ns3A:39.37"],["6C2M_C_SUEC1203_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"PHE A  43;VAL A  55;GLY A  58;ARG A 155;ASP A 168","None","1.28A","6c2mC-1ns3A:30.6","6c2mC-1ns3A:39.37"],["6C2M_C_SUEC1203_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"PHE A  43;VAL A  55;GLY A  58;LEU A 135;ASP A 168","None","0.79A","6c2mC-1ns3A:30.6","6c2mC-1ns3A:39.37"],["6C2M_D_SUED1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",8,"GLN A  41;HIS A  57;GLY A  58;VAL A  78;ARG A 123;GLY A 137;ALA A 156;ALA A 157","None","0.85A","6c2mD-1ns3A:30.4","6c2mD-1ns3A:39.37"],["6C2M_D_SUED1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",8,"HIS A  57;GLY A  58;VAL A  78;ARG A 123;GLY A 137;PHE A 154;ALA A 156;ALA A 157","None","0.63A","6c2mD-1ns3A:30.4","6c2mD-1ns3A:39.37"],["6C2M_D_SUED1202_0","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",5,"HIS A  57;GLY A  58;VAL A  78;GLY A 137;ARG A 155","None","1.02A","6c2mD-1ns3A:30.4","6c2mD-1ns3A:39.37"],["6C2M_D_SUED1202_1","NS3 PROTEASE","1ns3","NS3 PROTEASE","Hepacivirus C",6,"PHE A  43;VAL A  55;ASP A  81;LEU A 135;VAL A 158;ASP A 168","None","0.67A","6c2mD-1ns3A:30.4","6c2mD-1ns3A:39.37"]]